𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Delayed hypersensitivity reactions of cancer patients to antigens on lymphoid cell lines

✍ Scribed by P. H. Levine; J. H. C. Ho; F. Nkrumah; P. Periman; N. Mourali; G. Cannon; M. B. Middleton; I. V. Perkins; R. Herberman


Publisher
John Wiley and Sons
Year
1978
Tongue
French
Weight
543 KB
Volume
22
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Four‐hundred and fifty niné cancer patients were skin tested with extracts from five lymphoid cell lines. More than 50% of patients with lymphoma had positive skin tests with the extracts prepared from the cell line derived from Burkitt's lymphoma (BL) and more than 50% of nasopharyngeal carcinoma (NPC) patients reacted to the NPC‐derived cell line extracts. Although the significant association between patient diagnosis and origin of cell lines suggested that tumor‐associated antigens were responsible for the pattern of delayed hyper‐sensitivity, problems in standardization of antigen potency and non‐specificity need to be resolved before this in vivo assay achieves its full potential.


📜 SIMILAR VOLUMES


Sequential evaluation of cutaneous delay
✍ F. K. Nkrumah; R. Herberman; R. Biggar; I. V. Perkins 📂 Article 📅 1977 🏛 John Wiley and Sons 🌐 French ⚖ 507 KB

## Abstract Delayed cutaneous hypersensitivity reactions to standard recall antigens (candidin, mumps and PPD), to crude membrane extracts of a cell line derived from Burkitt's lymphoma (Raji) and to a cell line derived from normal lymphocytes (F265) were sequentially evaluated in 44 patients with

Specific and aspecific immune responsive
✍ Ercole Sega; Marcella Mottolese; Paola Cordiali-Fei; Gennaro Citro; Sergio Coliz 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 661 KB

## Abstract The ability of a lung cancer‐associated antigen (LCAA) to provoke specific cutaneous delayed‐hypersensitivity reactions has been studied on a group of 59 lung cancer patients. Biological activity of LCAA, monitored by skin testing, was demonstrated in 32% (17 of 53) of lung cancer patie

Cis-diamminedichloroplatinum(II) augment
✍ Hayashi, Hitoshi; Nio, Yoshinori; Kawabata, Kazuya; Araya, Shinichi; Imamura, Ma 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 809 KB

Previous studies have demonstrated the immunomodulatory effects of cisplatin under certain conditions. The present study was designed to clarify whether cisplatin modulates the expression of surface antigens, especially human leukocyte antigen (HLA), on human tumor cell lines and/or augments the sus